Authors: Ioannidis, JPA Haidich, AB Pappa, M Pantazis, N Kokori, SI Tektonidou, MG Contopoulos-Ioannidis, DG Lau, J

Citation: Jpa. Ioannidis et al., Comparison of evidence of treatment effects in randomized and nonrandomized studies, J AM MED A, 286(7), 2001, pp. 821-830

Authors: Tektonidou, MG Ioannidis, JPA Moyssakis, I Boki, KA Vassiliou, V Vlachoyiannopoulos, PG Kyriakidis, MK Moutsopoulos, HM

Citation: Mg. Tektonidou et al., Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome, ANN RHEUM D, 60(1), 2001, pp. 43-48

Authors: Tektonidou, MG Ioannidis, JPA Boki, KA Vlachoyiannopoulos, PG Moutsopoulos, HM

Citation: Mg. Tektonidou et al., Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome, QJM-MON J A, 93(8), 2000, pp. 523-530

Authors: Tektonidou, MG Petrovas, CA Ioannidis, JPA Vlachoyiannopoulos, PG Moutsopoulos, HM

Citation: Mg. Tektonidou et al., Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations, EUR J CL IN, 30(7), 2000, pp. 646-652

Authors: Ioannidis, JPA Tektonidou, MG Vlachoyiannopoulos, PG Stavropoulos-Giokas, C Spyropoulou-Vlachou, M Reveille, JD Arnett, FC Moutsopoulos, HM

Citation: Jpa. Ioannidis et al., HLA associations of anti-beta2 glycoprotein I response in a Greek cohort with antiphospholipid syndrome and meta-analysis of four ethnic groups, HUMAN IMMUN, 60(12), 1999, pp. 1274-1280